![Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery | Nature Protocols Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery | Nature Protocols](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41596-022-00755-x/MediaObjects/41596_2022_755_Fig1_HTML.png)
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery | Nature Protocols
![A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability | npj Vaccines A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-022-00549-y/MediaObjects/41541_2022_549_Fig1_HTML.png)
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability | npj Vaccines
![A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice - ScienceDirect A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761320303265-fx1.jpg)
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice - ScienceDirect
![Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report](https://www.frontiersin.org/files/Articles/798095/fmed-08-798095-HTML/image_m/fmed-08-798095-g001.jpg)
Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
![Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action | npj Vaccines Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action | npj Vaccines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41541-021-00369-6/MediaObjects/41541_2021_369_Fig1_HTML.png)
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action | npj Vaccines
Short Oligonucleotides Facilitate Co-transcriptional Labeling of RNA at Specific Positions | Journal of the American Chemical Society
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
![Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy](https://www.cell.com/cms/attachment/9cf7330b-8ae7-442c-9378-eb618ecbd9a2/gr1.jpg)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
![Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science](https://pubs.acs.org/cms/10.1021/acscentsci.1c00197/asset/images/large/oc1c00197_0002.jpeg)
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
![Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ad474937-ffe8-4da3-8b71-d0ce26839fbf/exp2120-fig-0001-m.jpg)
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
![Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement Biomolecules | Free Full-Text | Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement](https://pub.mdpi-res.com/biomolecules/biomolecules-11-00787/article_deploy/html/images/biomolecules-11-00787-g001.png?1621766580)